Sotera Health Company (NASDAQ:SHC) Q1 2022 Results Conference Call May 5, 2022 9:00 AM ET
Company Participants
Michael Petras - Chairman and CEO
Scott Leffler - CFO
Conference Call Participants
Sean Dodge - RBC Capital
Luke Sergott - Barclays
Matt Miksic - Credit Suisse
Patrick Donnelly - Citi
Matthew Mishan - KeyBanc
Dave Windley - Jefferies
Michael Polark - Wolfe Research
Casey Woodring - JPMorgan
Operator
Good morning. This is Joe and welcome to Sotera Health's First Quarter 2022 Results Call. You may find today's press release and accompanying supplemental slides in the Investors section of the Company's website at soterahealth.com. This webcast is being recorded, and a replay will be available in the Investors section of the Sotera Health website.
On the call today are Michael Petras, Chairman and Chief Executive Officer; and Scott Leffler, Chief Financial Officer.
During the call, some of the statements the Company makes may be considered forward-looking statements. The matters addressed in these statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected or implied. Please refer to Sotera Health's SEC filings and the forward-looking statement slide at the beginning of the presentation for a description of these risks and uncertainties. The Company assumes no obligation to update any such forward-looking statements.
Please note that during the discussion today, the Company will present both GAAP and non-GAAP financial measures, including adjusted EBITDA, adjusted EPS and net leverage ratio. A reconciliation of non-GAAP to GAAP measures for all relevant periods may be found in the schedules attached to the Company's press release and in its supplemental slides. [Operator Instructions] This conference is being recorded.
I would now like to turn the call over to Sotera Health's Chairman and CEO, Michael Petras. Please go ahead.
Michael Petras
Good morning, everyone, and thank you for joining us on Sotera Health's First Quarter 2022 Earnings Call. I'm very pleased this morning to be reporting another quarter of double-digit top and bottom line growth as compared to the same quarter in the prior year. While both the pandemic and the geopolitical landscape have impacted the labor markets and supply chains, the macro environment continues to experience more disruption than many of us have seen in our lifetimes.
Despite this backdrop, Sotera Health has continued to deliver growth consistently in each quarter we have reported as a public company and throughout our history. Scott will provide more detail in a moment, but here are some of the highlights of our first quarter performance. We reported total revenue growth of 12% and adjusted EBITDA growth of 10% compared to the first quarter of 2021.